OAN Staff Katherine Mosack
5:00 PM – Friday, December 19, 2025
President Donald Trump announced on Friday that nine major pharmaceutical companies have agreed to deals aimed at lowering prescription drug prices for American patients.
During a White House event, leaders from these pharmaceutical companies joined the 47th President to unveil the agreements. The participating manufacturers are Amgen, Bristol Myers Squibb, Boehringer Ingelheim, Genentech, Gilead Sciences, GSK, Merck, Novartis, and Sanofi.
Trump has long highlighted the unfair burden on Americans, who pay far higher prices for medications than patients in any other country.
This summer, he sent letters to 17 pharmaceutical companies…




